Role of apoptosis-inducing factor in perinatal hypoxic-ischemic brain injuryJuan Rodriguez，Tao Li，Yiran Xu，Yanyan Sun，Changlian Zhu205-213
Therapeutic potential of neuromodulation for demyelinating diseasesElliot H. Choi，Chioma Nwakalor，Nolan J. Brown，Joonho Lee，Michael Y. Oh，In Hong Yang214-217
Dysfunctional glia: contributors to neurodegenerative disordersMarta Sidoryk-W?grzynowicz，Lidia Stru?yńska218-222
Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophyllsMikhail A. Filippov，Olga G. Tatarnikova，Natalia V. Pozdnyakova，Vasily V. Vorobyov223-233
Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studiesClaudio Giuliano，Silvia Cerri，Fabio Blandini234-241
Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravisFrancisco J. Barrantes242-246
Hydrogel-based local drug delivery strategies for spinal cord repairRobert B. Shultz，Yinghui Zhong247-253
Altered physiology of gastrointestinal vagal afferents following neurotraumaEmily N. Blanke，Gregory M. Holmes，Emily M. Besecker254-263
Prospects for intelligent rehabilitation techniques to treat motor dysfunctionCong-Cong Huo，Ya Zheng，Wei-Wei Lu，Teng-Yu Zhang，Dai-Fa Wang，Dong-Sheng Xu，Zeng-Yong Li264-269
